Susquehanna International Group
EBS icon

Susquehanna International Group’s Emergent Biosolutions EBS Stock Holding History

Susquehanna International Group’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$402K Sell
48,439
-329,273
-87% -$3.41M ﹤0.01% 10199
2025
Q4 		$4.67M Buy
377,712
+98,759
+35% +$1.06M ﹤0.01% 4133
2025
Q3 		$2.46M Buy
278,953
+35,156
+14% +$273K ﹤0.01% 5350
2025
Q2 		$1.56M Sell
243,797
-605,576
-71% -$3.47M ﹤0.01% 6342
2025
Q1 		$4.13M Sell
849,373
-71,410
-8% -$591K ﹤0.01% 4015
2024
Q4 		$8.8M Buy
920,783
+476,118
+107% +$4.37M ﹤0.01% 2814
2024
Q3 		$3.71M Buy
444,665
+220,162
+98% +$2M ﹤0.01% 4142
2024
Q2 		$1.53M Buy
+224,503
New +$966K ﹤0.01% 5626
2024
Q1 		– Sell
-55,059
Closed -$124K – 12428
2023
Q4 		$132K Sell
55,059
-299,006
-84% -$703K ﹤0.01% 11085
2023
Q3 		$1.2M Buy
354,065
+66,052
+23% +$366K ﹤0.01% 6222
2023
Q2 		$2.12M Sell
288,013
-266,925
-48% -$2.48M ﹤0.01% 5032
2023
Q1 		$5.75M Buy
554,938
+509,520
+1,122% +$6.16M ﹤0.01% 3248
2022
Q4 		$536K Sell
45,418
-51,851
-53% -$802K ﹤0.01% 7675
2022
Q3 		$2.04M Buy
97,269
+68,858
+242% +$1.92M ﹤0.01% 4891
2022
Q2 		$882K Sell
28,411
-16,170
-36% -$552K ﹤0.01% 6834
2022
Q1 		$1.83M Sell
44,581
-51,337
-54% -$2.26M ﹤0.01% 5679
2021
Q4 		$4.17M Buy
95,918
+39,836
+71% +$1.8M ﹤0.01% 4054
2021
Q3 		$2.81M Buy
56,082
+2,910
+5% +$176K ﹤0.01% 5091
2021
Q2 		$3.35M Buy
53,172
+4,063
+8% +$261K ﹤0.01% 4784
2021
Q1 		$4.56M Sell
49,109
-28,018
-36% -$2.87M ﹤0.01% 4082
2020
Q4 		$6.91M Sell
77,127
-55,583
-42% -$5.1M ﹤0.01% 2955
2020
Q3 		$13.7M Buy
132,710
+110,926
+509% +$12M ﹤0.01% 1851
2020
Q2 		$1.72M Sell
21,784
-20,863
-49% -$1.55M ﹤0.01% 4761
2020
Q1 		$2.47M Buy
42,647
+16,499
+63% +$951K ﹤0.01% 3603
2019
Q4 		$1.41M Sell
26,148
-30,110
-54% -$1.63M ﹤0.01% 4904
2019
Q3 		$2.94M Sell
56,258
-1,857
-3% -$86.5K ﹤0.01% 3528
2019
Q2 		$2.81M Buy
+58,115
New +$2.79M ﹤0.01% 3550
2018
Q1 		– Sell
-9,914
Closed -$494K – 9467
2017
Q4 		$461K Buy
+9,914
New +$417K ﹤0.01% 6797
2017
Q1 		– Sell
-10,350
Closed -$315K – 9126
2016
Q4 		$340K Buy
+10,350
New +$310K ﹤0.01% 7744
2015
Q4 		– Sell
-12,761
Closed -$445K – 9520
2015
Q3 		$364K Sell
12,761
-4,251
-25% -$140K ﹤0.01% 7700
2015
Q2 		$561K Sell
17,012
-1,346
-7% -$41.7K ﹤0.01% 7402
2015
Q1 		$528K Buy
18,358
+6,247
+52% +$179K ﹤0.01% 6993
2014
Q4 		$330K Buy
+12,111
New +$289K ﹤0.01% 7964
2014
Q3 		– Sell
-9,700
Closed -$218K – 9514
2014
Q2 		$218K Sell
9,700
-6,834
-41% -$159K ﹤0.01% 8919
2014
Q1 		$418K Buy
+16,534
New +$418K ﹤0.01% 7032

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Susquehanna International Group's EBS Position: Q1 2026 in Review

Susquehanna International Group reduced its Emergent Biosolutions (EBS) stake by 87% in Q1 2026, selling an estimated $3.41M and leaving 48,439 shares worth $402K. The position accounts for ﹤0.01% of the portfolio, ranked #10199.

Susquehanna International Group first reported a position in EBS in Q1 2014 and has held it in 35 quarters since. The position peaked at $13.7M in Q3 2020. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

  • Susquehanna International Group held 48,439 shares of Emergent Biosolutions worth $402K as of Q1 2026.
  • Susquehanna International Group sold 329,273 Emergent Biosolutions shares in Q1 2026, an estimated $3.41M.
  • Emergent Biosolutions made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #10199 holding.
  • Susquehanna International Group first reported a position in Emergent Biosolutions in Q1 2014 and has held it in 35 quarters since.
  • Susquehanna International Group's Emergent Biosolutions position peaked at $13.7M in Q3 2020.
  • 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.